Comparative effectiveness of methadone take-home dose initiation in British Columbia, Canada: protocol for a population-based retrospective cohort study using target trial guidelinesMd. Belal Hossain, Brenda Carolina Guerra-Alejos, Megan Kurz, Jeong Eun Min, Mohammad Ehsanul Karim, Shaun Seaman, Paxton Bach, Robert W Platt, Paul Gustafson, Julie Bruneau, Lawrence McCandless, Maria Eugenia Socías, Bohdan Nosyk
5 March 2025
Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorderCatharine Montgomery, Yasir Abbasi, Devon De Silva, Rosalind Gittins, Andrew Jones, Marie-Claire Van Hout
18 February 2025
Supervised Injecting Room Cohort Study (SIRX): study protocolAshleigh C Stewart, Matthew Hickman, Paul A Agius, Nick Scott, Jack Stone, Amanda Roxburgh, Daniel O’Keefe, Peter Higgs, Thomas Kerr, Mark A Stoové, Alexander Thompson, Sione Crawford, Josephine Norman, Dylan Vella-Horne, Zachary LloydSee the full list of authors
11 February 2025
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotheray for methamphetamine use disorder (the KAPPA trial)Kathryn Fletcher, Nadine Ezard, Krista J Siefried, Harriet MacDonald, Liam Acheson, Gillinder Bedi, Alexandre Guerin, Elizabeth Knock, Michael Millard, Robert May, Jonathan Brett, Jess Doumany, Celia Morgan, Brendan Clifford
10 February 2025
Trial protocol of an open-label pilot study of oral ltrexone–propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)Krista J Siefried, Liam Acheson, Brendan Clifford, Carl Moller, Jonathan Brett, Michael Christmass, Adrian John Dunlop, Paul S Haber, Didier Jutras-Aswad, Nicholas Lintzeris, Kirsten Morley, Steven Shoptaw, Madhukar H Trivedi, Nadine Ezard
7 February 2025
Opioid agonist therapy discontinuation in British Columbia: a cross-sectional study of people who access harm reduction servicesKimia Ziafat, Lisa Liu, Bradley Kievit, Kristi Papamihali, Brittany Graham, Michael Otterstatter, Jane A Buxton
15 January 2025
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)Mette Kruse Klausen, Tugba Kuzey, Julie Niemann Pedersen, Signe Keller Justesen, Line Rasmussen, Ulla B Knorr, Graeme Mason, Claus Thorn Ekstrøm, Jens Juul Holst, George Koob, Helene Benveniste, Nora D Volkow, Gitte M Knudsen, Tina Vilsbøll, Anders Fink-Jensen
8 January 2025
Challenges of smoking cessation in users of non-invasive stimulation technologies in Iran: a parallel convergent mixed-methods studyMohammad Hasan Sahebihagh, Mina Hosseinzadeh, Mojgan Mirghafourvand, Parvin Sarbakhsh, Hossein Nemati
26 December 2024
Feasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: a pilot evaluation study protocolFilip Djordjevic, Ashleigh Cara Stewart, Dylan Vella-Horne, Zoe Gleeson, Damian Pavlyshyn, Matthew Gill, Rebekka Petrovic, Nick Scott, Peter Higgs, Alexis Roth, Ben Cocchiaro, Paul Dietze, Daniel O’Keefe
20 December 2024
Patient experience of opioid use disorder treatment medications: a systematic review of contemporary qualitative researchNatalie Lowry, Carina Najia, Mike Kelleher, Luke Mitcheson, John Marsden
4 December 2024